FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002348917> ?p ?o ?g. }

• W2002348917 endingPage "300" @default.
• W2002348917 startingPage "291" @default.
• W2002348917 abstract "Background. This study was conducted to determine the efficacy and tolerability of fluoxetine and desipramine in treating depressive symptoms in women with cancer. Method. In this prospective, 6-week, double-blind, placebo-controlled trial, we compared fluoxetine with desipramine in treating depressive symptoms in 40 women diagnosed with cancer. Scales used to measure efficacy and tolerability were the Hamilton Depression Rating Scale (HAM-D), the Hamilton Anxiety Rating Scale (HAM-A), the Clinical and Patient's Global Impression (CGI and PGI) scales, the Functional Living Index for Cancer (FLIC), the Memorial Pain Assessment Card (MPAC), and the SF-36 Health Survey. Results. Fluoxetine and desipramine treatments improved depression and anxiety symptoms. There was a trend towards significance in improvement of FLIC scores (as evidenced by greater numerical improvements with fluoxetine treatment). Fluoxetine treatment alone was associated with statistically significant improvements in MPAC Mood scale scores. Both treatments showed statistically significant improvements in the quality of life SF-36 scores in Role Emotional, Social Functioning, Mental Health, and Vitality. Conclusions. Both fluoxetine and desipramine were effective and well-tolerated in improving depressive symptoms and quality of life in women with advanced cancer. Fluoxetine may offer greater benefit to these patients, as evidenced by greater improvements in fluoxetine-treated patients on several quality of life measures. Our results, while meaningful, should be confirmed in a larger patient sample. However, experience from studies of antidepressant use in patients with advanced cancer has shown that intercurrent disease and treatment variables make it difficult to conduct large studies. © 1998 John Wiley & Sons, Ltd." @default.
• W2002348917 created "2016-06-24" @default.
• W2002348917 creator A5032744893 @default.
• W2002348917 creator A5044271662 @default.
• W2002348917 creator A5048077385 @default.
• W2002348917 creator A5070611924 @default.
• W2002348917 creator A5079953196 @default.
• W2002348917 date "1998-07-01" @default.
• W2002348917 modified "2023-09-27" @default.
• W2002348917 title "A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer" @default.
• W2002348917 cites W1640799435 @default.
• W2002348917 cites W1839280266 @default.
• W2002348917 cites W1894663696 @default.
• W2002348917 cites W1977250577 @default.
• W2002348917 cites W1978474541 @default.
• W2002348917 cites W1979851007 @default.
• W2002348917 cites W1995415250 @default.
• W2002348917 cites W2039086573 @default.
• W2002348917 cites W2044678525 @default.
• W2002348917 cites W2061378977 @default.
• W2002348917 cites W2070095833 @default.
• W2002348917 cites W2081856571 @default.
• W2002348917 cites W2082460580 @default.
• W2002348917 cites W2151010580 @default.
• W2002348917 cites W2151903962 @default.
• W2002348917 cites W2160070901 @default.
• W2002348917 cites W2170862598 @default.
• W2002348917 cites W2269772723 @default.
• W2002348917 cites W2424111404 @default.
• W2002348917 cites W4299647588 @default.
• W2002348917 doi "https://doi.org/10.1002/(sici)1099-1611(199807/08)7:4<291::aid-pon361>3.0.co;2-u" @default.
• W2002348917 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9741068" @default.
• W2002348917 hasPublicationYear "1998" @default.
• W2002348917 type Work @default.
• W2002348917 sameAs 2002348917 @default.
• W2002348917 citedByCount "137" @default.
• W2002348917 countsByYear W20023489172012 @default.
• W2002348917 countsByYear W20023489172013 @default.
• W2002348917 countsByYear W20023489172014 @default.
• W2002348917 countsByYear W20023489172015 @default.
• W2002348917 countsByYear W20023489172016 @default.
• W2002348917 countsByYear W20023489172017 @default.
• W2002348917 countsByYear W20023489172018 @default.
• W2002348917 countsByYear W20023489172020 @default.
• W2002348917 countsByYear W20023489172021 @default.
• W2002348917 countsByYear W20023489172022 @default.
• W2002348917 countsByYear W20023489172023 @default.
• W2002348917 crossrefType "journal-article" @default.
• W2002348917 hasAuthorship W2002348917A5032744893 @default.
• W2002348917 hasAuthorship W2002348917A5044271662 @default.
• W2002348917 hasAuthorship W2002348917A5048077385 @default.
• W2002348917 hasAuthorship W2002348917A5070611924 @default.
• W2002348917 hasAuthorship W2002348917A5079953196 @default.
• W2002348917 hasConcept C118552586 @default.
• W2002348917 hasConcept C126322002 @default.
• W2002348917 hasConcept C138496976 @default.
• W2002348917 hasConcept C142724271 @default.
• W2002348917 hasConcept C15744967 @default.
• W2002348917 hasConcept C170493617 @default.
• W2002348917 hasConcept C197934379 @default.
• W2002348917 hasConcept C204787440 @default.
• W2002348917 hasConcept C27081682 @default.
• W2002348917 hasConcept C2775864247 @default.
• W2002348917 hasConcept C2776000289 @default.
• W2002348917 hasConcept C2776134451 @default.
• W2002348917 hasConcept C2777696351 @default.
• W2002348917 hasConcept C2778375690 @default.
• W2002348917 hasConcept C2779177272 @default.
• W2002348917 hasConcept C2779951463 @default.
• W2002348917 hasConcept C2780250439 @default.
• W2002348917 hasConcept C542102704 @default.
• W2002348917 hasConcept C558461103 @default.
• W2002348917 hasConcept C71924100 @default.
• W2002348917 hasConcept C83849319 @default.
• W2002348917 hasConceptScore W2002348917C118552586 @default.
• W2002348917 hasConceptScore W2002348917C126322002 @default.
• W2002348917 hasConceptScore W2002348917C138496976 @default.
• W2002348917 hasConceptScore W2002348917C142724271 @default.
• W2002348917 hasConceptScore W2002348917C15744967 @default.
• W2002348917 hasConceptScore W2002348917C170493617 @default.
• W2002348917 hasConceptScore W2002348917C197934379 @default.
• W2002348917 hasConceptScore W2002348917C204787440 @default.
• W2002348917 hasConceptScore W2002348917C27081682 @default.
• W2002348917 hasConceptScore W2002348917C2775864247 @default.
• W2002348917 hasConceptScore W2002348917C2776000289 @default.
• W2002348917 hasConceptScore W2002348917C2776134451 @default.
• W2002348917 hasConceptScore W2002348917C2777696351 @default.
• W2002348917 hasConceptScore W2002348917C2778375690 @default.
• W2002348917 hasConceptScore W2002348917C2779177272 @default.
• W2002348917 hasConceptScore W2002348917C2779951463 @default.
• W2002348917 hasConceptScore W2002348917C2780250439 @default.
• W2002348917 hasConceptScore W2002348917C542102704 @default.
• W2002348917 hasConceptScore W2002348917C558461103 @default.
• W2002348917 hasConceptScore W2002348917C71924100 @default.
• W2002348917 hasConceptScore W2002348917C83849319 @default.
• W2002348917 hasIssue "4" @default.
• W2002348917 hasLocation W20023489171 @default.
• W2002348917 hasLocation W20023489172 @default.

• next